181O Interim analysis (IA) of the atezolizumab (atezo) + sacituzumab govitecan (SG) arm in patients (pts) with triple-negative breast cancer (TNBC) in MORPHEUS-pan BC: A phase Ib/II study of multiple treatment (tx) combinations in pts with locally advanced/metastatic BC (LA/mBC)

Saved in:
Bibliographic Details
Published in:ESMO open 2024-05, Vol.9, p.103203, Article 103203
Main Authors: Schmid, P., Loi, S., De la Cruz Merino, L., Yerushalmi, R., Im, S-A., Sonnenblick, A., Garcia, M. Martinez, Candilejo, I. Moreno, Kennedy, L.C., Griffiths, K.L., Schwab, R., Young, F., Liao, L., Dupree, K., Kim, S-B.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2024.103203